Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma

Authors

  • Enrico Derenzini,

    1. Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Institute of Hematology and Medical Oncology “L. & A. Seragnòli”, Bologna, Italy
    Search for more papers by this author
  • Beatrice Casadei,

    1. Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Institute of Hematology and Medical Oncology “L. & A. Seragnòli”, Bologna, Italy
    Search for more papers by this author
  • Alessandro Broccoli,

    1. Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Institute of Hematology and Medical Oncology “L. & A. Seragnòli”, Bologna, Italy
    Search for more papers by this author
  • Letizia Gandolfi,

    1. Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Institute of Hematology and Medical Oncology “L. & A. Seragnòli”, Bologna, Italy
    Search for more papers by this author
  • Cinzia Pellegrini,

    1. Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Institute of Hematology and Medical Oncology “L. & A. Seragnòli”, Bologna, Italy
    Search for more papers by this author
  • Pier Luigi Zinzani

    1. Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Institute of Hematology and Medical Oncology “L. & A. Seragnòli”, Bologna, Italy
    Search for more papers by this author

No abstract is available for this article.

Ancillary